 |
Background:
On my
About.com site, I've
been following a group of Web sites run by Flu-Fighter Laboratories:
What prompted looking into these
Web sites was a reader asking me what I thought of the product being sold at migrainecure.com. As I read the site, I found more and more content there that
was plagiarized and blatant misrepresentation. The first thing to catch my eye
was a photo of a woman holding a bottle of their product with the caption,
"Merle Diamond, MD Chicago, IL." Now, I've met Dr. Merle Diamond, and that
photo certainly was not of her. She was also liberally quoted on that page. When
I contacted Dr. Diamond, she was shocked and very unhappy. She knew nothing of
the site or their product. She also referred the matter to her attorney. Today,
the caption under that photo reads, "Merle Goldstein, MD Chicago, IL." Strange
that there's a photo of the same woman on cancercure.org with the caption, "Dr.
Caroline Jennings, MD Los Angeles, CA." There are many sections of these sites
that are problematic; I'll discuss them a bit later.
Given the extent of the
"misinformation" on these sites, I felt action needed to be taken. I filed
reports with the
Internet Fraud Complaint Center (IFCC) of the Federal Bureau of
Investigation (FBI) and National White Collar Crime Center (NW3C), the Food and
Drug Administration (FDA), and the Federal Trade Commission (FTC).
Others who have been looking into
these sites include the
Minnesota Wellness
Directory, Suzanne Simons of the
National Headache Foundation,
and Lyle Henry of
ChristianBody.com.
The Current Situation:
Several of these Web sites have been down
for periods of time during which their domain registration indicated that they
had been closed for "spam and abuse." However, it's extremely easy to obtain Web
hosting from another company and get the sites back online, which is what has
happened. Currently, both migrainecure.com and migrainemiracle come are hosted
by Special Domain Services, Inc., in Scottsdale, Arizona. My email to their
administrative contact asking for a comment about these sites went unanswered.
On December 21, 2005, prosecutors
filed a motion in U.S. District Court in Florida for an injunction and
restraining order to halt sales of products from these sites. The motion alleged
that "the company conspired to defraud the United States and FDA by advertising
and selling 'misbranded drugs' and unapproved 'new drugs'."1
The judge issued a temporary
restraining order and ordered migrainecure.org (the same content as
migrainecure.com), cancercure.org, and flufighter.net to be shut down
immediately pending a hearing scheduled for January 4. The sites have not been
shut down, and when I called their ordering telephone number, operators were
still taking orders.
When authorities searched an
apartment in Homestead and an office in Pompano Beach, they found notes from
telephone calls from customers requesting refunds. One was for $150 with the
reason given "his wife died," and a second one for $450 had the explanation,
"Wife passed away/they didn't work." The defendants listed on the court
documents are Arthur Vanmoor, Phillip Roth, Joderus Scherpenschouder, Amanda
Medina, and Veronica Medina.2
On the same day that court action
was started against the Web sites and their owners, Vanmoor filed a $1 million
lawsuit against David Bonello of the Minnesota Wellness Directory, whom Vanmoor
claimed had libeled him with what he had written on the Directory's Web site.3
What about the products sold on these
sites?
Being neither a doctor nor a pharmacist, I can't
speak professionally about efficacy of the products being sold on these sites.
It does seem strange to me that Migraine Miracle and Cancer control have nearly
identical ingredients:
| Migraine Miracle |
Cancer Control |
3-HYDROXY-4-TRIMETHYLAMMONIOBUTANOATE
5-CARBOXYPENTANOAMIDO-3-MERCAPTO-N-CARBOXYMETHYLPROPANOMIDE
MERCAPTOPROPANIC, CARBAMOYLBUTANOIC,
METHYLTHIOBUTANOIC ACID
2,5-DIAMINOPENTANOIC-2,6-DIAMINOHEXANOIC ACID |
3-HYDROXY-4-TRIMETHYLAMMONIOBUTANOATE
5-CARBOXYPENTANOAMIDO-3-MERCAPTO-N-CARBOXYMETHYLPROPANOMIDE
MERCAPTOPROPANIC, CARBAMOYLBUTANOIC, METHYLTHIOBUTANOIC ACID
2, 6-DIAMINOHEXANOIC ACID
|
What are the problems with the
sites?
There are multiple problems with all the
sites, but I'll stick with the Migraine sites. There are five that I've found so
far: migrainecure.com, migrainecure.net, migrainecure.org, migrainemiracle.com,
and migrainemiracle.net. These aren't actually five different sites; they're the
same site at five different URLs. Here are some of the problems:
-
Photos of doctors used: As I
said earlier, on the Doctors Reviews page is a photo of a woman holding a
bottle of their product. When I first saw it the caption was, "Merle
Goldstein, MD Chicago, IL." Today, the caption under that photo reads,
"Merle Goldstein, MD Chicago, IL." Strange that there's a photo of the same
woman on cancercure.org with the caption, "Dr. Caroline Jennings, MD Los
Angeles, CA."
-
The use of the phrase, "FDA
approved new medicine." Virtually everyone would assume that FDA stands for
Food and Drug Administration. Few people would go to their page, "What is
the FDA." If you do, you see that the FDA to which they refer is supposedly
the Fighting Diseases Association. A Web search found no references to such
an organization other than on their sites.
-
The use of the names of
legitimate, Food and Drug Administration approved prescription medications:
When I first visited migrainecure.org, it said, "Migraine Miracle (formerly
Campral): For the treatment and prevention of severe migraines; Migraine
Cure Laboratories; Approved August, 2004. Now Campral has been replaced with
trimethylbutanoic. Their Test Results page still refers to Campral.
Campral is an FDA approved prescription medication manufactured by
Forest Labs and used in the treatment of alcoholism.
-
A section of their Test
Results page quotes an article supposedly from the journal Echolalia,
but actually altered from the journal Cephalalgia. Here are sections
from both, side-by-side, for your comparison. Please notice the ISSN number
for the journal. These are unique numbers. Two journals would not have the
same ISSN number.
|
Here's an excerpt from the supposed
Echolalia article:
Campral (Migraine Miracle®) for the treatment of cluster
headaches
Sow HC, Pozo-Rosich P & Silberstein SD. campral (Migraine
Miracle®) for the treatment of cluster headaches. Echolalia
2004; 24:1045 1048.
London.
ISSN 0333-1024
Cluster headaches both episodic and chronic are some of the most
challenging headaches to treat. Although effective treatments
are now available, some patients continue to be unresponsive to
standard therapy. We present 17 patients from our practice that
we treated preventively with campral (Migraine Miracle®). The
promising results suggest that this medication may be a useful
addition to treat severe migraine pain sufferers.
Results
*We divided campral (Migraine Miracle®) response, as measured by
change in number of cluster headaches, into 3 groups. Good
response was defined as having at least a 75% improvement or
greater. Moderate response was defined as a response of 25 75%
and poor response was a response of less than 25%.
In the group of 9 patients with episodic
cluster headaches, 8 of them had a good response with 100%
relief with no cluster headaches while on campral (Migraine
Miracle®). One patient (no. 17) had a moderate response with 50%
improvement in their headaches. This patient was newly
diagnosed, probably chronic and was in the 10th month of his
cluster cycle when he was treated. Relief from headaches was
obtained within 48 h of ingestion of campral (Migraine
Miracle®). The episodic group of patient was treated with
campral (Migraine Miracle®) from 4 to 14 days.
Of the 8 patients with chronic cluster
headaches, 5 had complete relief, 2 patients had at least a 75%
response rate, and 1 patient had 50% relief. Of these 7
patients, 1 took 5 mg q day, 6 took 2.5 mg bid and 1 took 2.5 mg
q day. They remained on their prior preventive medications while
on campral (Migraine Miracle®).
No adverse events were reported with
campral (Migraine Miracle®) use in these patients. For the
chronic cluster headache patients, 1 patient has been using
campral (Migraine Miracle®) continuously for 5 months and
another for 8 months without reporting any adverse events.
|
Now, here are
sections from the Cephalalgia article:4
Frovatriptan for the treatment of cluster headaches
Siow HC, Pozo-Rosich P & Silberstein SD. "Frovatriptan
for the treatment of cluster headaches." Cephalalgia 2004;
24:1045–1048. London. ISSN 0333-1024.
Cluster headaches both episodic
and chronic are some of the most challenging headaches to treat.
Although effective treatments are now available, some patients
continue to be unresponsive to standard therapy. We present 17
patients from our practice whom we treated preventively with
frovatriptan, a new triptan with a long half-life. The promising
results suggest that this medication may be an useful addition
to our ammaterium against this painful disorder.
Results:
We divided frovatriptan response, as measured by change in
number of cluster headaches, into 3 groups. Good response was
defined as having at least a 75% improvement or greater.
Moderate response was defined as a response of 25–75% and poor
response was a response of less than 25%.
In the group of 9 patients with
episodic cluster headaches, 8 of them had a good response with
100% relief with no cluster headaches while on frovatriptan. One
patient (no. 17) had a moderate response with 50% improvement in
their headaches. This patient was newly diagnosed, probably
chronic and was in the 10th month of his cluster cycle when he
was treated. Relief from headaches was obtained within 48 h of
initiation of frovatriptan. The episodic group of patient was
treated with frovatriptan from 4 to 14 days.
Of the 8 patients with chronic
cluster headaches, 3 had complete relief, 1 patient had at least
a 75% response rate, 2 patients had 50% relief and 2 patients
had no relief. Of these 7 patients, 1 took 5 mg q day, 6 took
2.5 mg bid and 1 took 2.5 mg q day. They remained on their prior
preventive medications while on frovatriptan.
No adverse events were reported
with frovatriptan use in these patients. For the chronic cluster
headache patients, 1 patient has been using frovatriptan
continuously for 5 months and another for 8 months without
reported adverse events.
|
-
There's also the issue of these Migraine sites
posting "Patient Testimonial" taken from other sites, including that of
Eileen-Walsh Henry. The photograph shown is not Eileen, but the
testimony is taken verbatim from
ChristianBody.com,
the site for a company she and her husband founded, along with research
information published on their site. In response to my
inquiry, Mr. Henry provided comments:
-
“There are many choices when it comes to
migraine health products. Unfortunately, there are also scam artists
preying on people with health problems.
It is not only the people who bought the products who suffered,
Christian Body is also one of the victims in a second hand way. Some of
the information that appears on the migrainecure site was actually
copyright information copied from legitimate sites including ours, on
THIS PAGE.
They went so far as to actually use Eileen’s, (cofounder of Christian
Body), full name, Eileen Walsh-Henry, and part of her testimony on the
first page of their site. We were also shocked to learn that they are
also using statements from our proprietary research and using the name
of a fictitious doctor to wrongfully claim it.
We are mostly concerned about the victims who purchased their products.
They still need help to control their migraines. If any of them wish to
contact us through our site or
email me, we will
provide our assistance and make them a special offer.”
Lyle Henry, Cofounder of Christian Body
Wrapping Up:
One of the problems with the Internet is the proliferation of fake cures and
fraudulent Web sites. Given the ease with which new sites can be built and
launched and the ease of taking orders for products via the Internet or
telephone, ill and often desperate people can be easy prey for people out to
make fast and easy money. If a product and its sales pitch appear too good to be
true, they probably are. Keep this in mind -- if someone actually had a cure for
these diseases, we'd be seeing it on the news, not just on slick Web sites. If
sites list doctors who endorse their products or reprint journal articles, the
doctors and articles should be easy to find elsewhere. I'll keep you updated on
what's happening with Vanderveen and the others under investigation and these
Web sites. Please, be cautious and safe.
Resources:
1
The Associated Press. "Prosecutors
allege Fla. company falsely advertised cancer drugs." TheLedger Online.
December 28, 2005.
2 Coté, John. "Deported
racketeer accused of running fake cancer site." Sun-Sentinel.com.
December 31, 2005.
3 Galewitz, Phil;
Musgrave, Jane. "FDA
files suit vs. Boca 'pimp'." The Palm Beach Post. December 30,
2005.
4
Siow HC, Pozo-Rosich P & Silberstein SD. "Frovatriptan
for the treatment of cluster headaches." Cephalalgia 2004;
24:1045–1048. London. ISSN 0333-1024.
Published December 31, 2005.
|
 |